Table 1.
Patients’ characteristics and clinical features
Patient | Tumor location | N surgeries pre-bev | n bev cycles | Best response | Toxicity (grade) | PFS (mos) | OS (mos) |
---|---|---|---|---|---|---|---|
1 | R temporal | 3 | 11 | CR | none | 51 | 71 |
2 | R parietal | 1 | 12 | CR | none | 36 | 41 |
3 | R temporal | 1 | 1 | PD | brain hemorrhage | 3 | 4 |
4 | R parietal | 2 | 2 | SD | hepatic failure | 6 | 8 |
5 | L temporal | 1 | 9 | CR | none | 40 | 48 |
6 | multifocal | 1 | 2 | PD | brain hemorrhage | 6 | 7 |
7 | L occipital | 1 | NA | NA | NA | NA | NA |
8 | multifocal | 1 | NA | NA | NA | NA | NA |
9 | L parietal | 2 | NA | NA | NA | NA | NA |
10 | R parietal | 1 | NA | NA | NA | NA | NA |
11 | R temporal | 1 | NA | NA | NA | NA | NA |
12 | L parietal | 1 | NA | NA | NA | NA | NA |